1674416 - Crispr Therapeutics AG - SEC Form 4 Insider Trading Screener

Manufactured Goods - Chemicals - Biological Products, (No Diagnostic Substances) - CRSP (1674416)
General
Tickers
Insider
Sh Price $
Lqdty M$
Date
Filing Date
  
Trade Date
  
Filing Delay
N Days Ago
Transaction Filing
P - Purchase
S - Sale
A - Grant
D - Sale to Iss
G - Gift
F - Tax
M - Option Ex
X - Option Ex
C - Cnv Deriv
W - Inherited
No deriv Multiple Days
Traded K$
Own Chg %
Industry
Insider Title   Officer
    COB
    CEO
    Pres
    COO
    CFO
    GC
    VP
  Director
  10% Own
  Other
Group by
Sort by
Max Results
Page
clear
Real-time CSV, Options, Alerts
70 results - Yahoo - Google - Finviz - Stockcharts - Tradingview - Stocktwits - SEC
TCcnt1d1w1m6m
P9+5+11+20+13
S10-0+0+0+0

X

Filing Date

Trade Date

Ticker

Insider Name

Insider Title

Trade Type 

Share Price

Shares Traded

Shares Owned

Own chg

Value Traded

1d ret

1w ret

1m ret

6m ret

D
2017-09-05
CRSPNovak RodgerCEOM - OptEx$1.81+3,8531,148,0070%+$6,974
DM
2017-08-31
CRSPNovak RodgerCEOS - Sale+OE$20.76-18,4701,148,007-2%-$383,393
DM
2017-08-28
CRSPNovak RodgerCEOM - OptEx$1.81+23,4141,162,624+2%+$42,379
DM
2017-08-28
CRSPNovak RodgerCEOS - Sale+OE$20.25-75,7951,162,624-6%-$1,534,869
M
2017-08-28
CRSPKulkarni SamarthChief Business OfficerS - Sale$20.08-27,154106,893-20%-$545,162
2017-08-28
CRSPEmster Kurt VonDirS - Sale$19.79-88,0111,951,359-4%-$1,741,738
M
2017-08-24
CRSPEmster Kurt VonDirS - Sale$19.42-22,7812,039,370-1%-$442,403
M
2017-08-22
CRSPEmster Kurt VonDirS - Sale$18.53-17,9892,062,151-1%-$333,336
M
2017-08-18
CRSPEmster Kurt VonDirS - Sale$18.52-3,1502,080,1400%-$58,345
M
2017-08-16
CRSPEmster Kurt VonDirS - Sale$19.06-34,1412,083,290-2%-$650,693
M
2017-08-14
CRSPEmster Kurt VonDirS - Sale$19.59-55,5692,117,431-3%-$1,088,561
M
2017-08-07
CRSPEmster Kurt VonDirS - Sale$18.63-35,4732,190,872-2%-$660,888
M
2017-08-04
CRSPDylan-Hyde TylerGCS - Sale$18.57-15,000153,204-9%-$278,479
M
2017-08-03
CRSPEmster Kurt VonDirS - Sale$17.81-50,4772,226,345-2%-$899,216
M
2017-07-31
CRSPEmster Kurt VonDirS - Sale$17.51-5,5122,276,8220%-$96,491
M
2017-07-27
CRSPEmster Kurt VonDirS - Sale$17.63-41,3122,282,334-2%-$728,134
M
2017-07-25
CRSPEmster Kurt VonDirS - Sale$17.60-32,9302,323,646-1%-$579,545
M
2017-07-13
CRSPEmster Kurt VonDirS - Sale$16.84-69,8592,356,576-3%-$1,176,710
M
2017-07-11
CRSPEmster Kurt VonDirS - Sale$16.56-31,9922,408,563-1%-$529,938
2017-07-05
CRSPEmster Kurt VonDirS - Sale$16.26-4,2542,440,5550%-$69,170
M
2017-06-28
CRSPEmster Kurt VonDirS - Sale$16.90-43,2022,444,809-2%-$730,125
M
2017-06-26
CRSPEmster Kurt VonDirS - Sale$17.08-81,4352,488,011-3%-$1,390,611
M
2017-06-22
CRSPEmster Kurt VonDirS - Sale$16.23-32,3682,569,446-1%-$525,302
D
2017-06-22
CRSPNovak RodgerCEOM - OptEx$1.81+10,8251,215,005+1%+$19,593
D
2017-06-22
CRSPNovak RodgerCEOS - Sale+OE$15.37-10,8251,215,005-1%-$166,388
DM
2017-06-19
CRSPNovak RodgerCEOM - OptEx$1.81+30,2221,215,005+3%+$54,702
DM
2017-06-19
CRSPNovak RodgerCEOS - Sale+OE$15.01-30,2221,215,005-2%-$453,511
DM
2017-06-08
CRSPNovak RodgerCEOM - OptEx$1.81+5,3031,215,0050%+$9,598
DM
2017-06-08
CRSPNovak RodgerCEOS - Sale+OE$15.02-5,3031,215,0050%-$79,628
D
2017-05-30
CRSPNovak RodgerCEOM - OptEx$1.81+3,6501,215,0050%+$6,607
D
2017-05-30
CRSPNovak RodgerCEOS - Sale+OE$15.02-3,6501,215,0050%-$54,829
DM
2017-05-16
CRSPNovak RodgerCEOM - OptEx$1.81+50,0001,215,005+4%+$90,500
DM
2017-05-16
CRSPNovak RodgerCEOS - Sale+OE$16.26-50,0001,215,005-4%-$812,859
D
2017-05-05
CRSPNovak RodgerCEOM - OptEx$1.81+6161,215,0050%+$1,1150
D
2017-05-05
CRSPNovak RodgerCEOS - Sale+OE$16.92-6161,215,0050%-$10,4260
DM
2017-05-02
CRSPNovak RodgerCEOM - OptEx$1.81+49,3841,215,005+4%+$89,385+2+2
DM
2017-05-02
CRSPNovak RodgerCEOS - Sale+OE$16.30-49,3841,215,005-4%-$805,183+2+2
2017-05-01
CRSPDylan-Hyde TylerGCS - Sale$16.61-1,852168,204-1%-$30,753+3+4
DM
2017-04-26
CRSPKulkarni SamarthChief Business OfficerM - OptEx$1.81+5,481134,047+4%+$9,9210-2
DM
2017-04-26
CRSPKulkarni SamarthChief Business OfficerS - Sale+OE$16.76-5,481134,047-4%-$91,8390-2
M
2017-04-26
CRSPDylan-Hyde TylerGCS - Sale$16.78-21,639170,056-11%-$363,0770-2
M
2017-04-21
CRSPDylan-Hyde TylerGCS - Sale$16.78-11,332183,695-6%-$190,109-1+1
DM
2017-04-21
CRSPKulkarni SamarthChief Business OfficerM - OptEx$1.81+11,615134,047+9%+$21,023-1+1
DM
2017-04-21
CRSPKulkarni SamarthChief Business OfficerS - Sale+OE$16.78-11,615134,047-8%-$194,942-1+1
DM
2017-04-19
CRSPNovak RodgerCEOM - OptEx$1.81+50,0001,215,005+4%+$90,500-20
DM
2017-04-19
CRSPNovak RodgerCEOS - Sale+OE$17.88-50,0001,215,005-4%-$893,918-20
DM
2017-04-19
CRSPKulkarni SamarthChief Business OfficerM - OptEx$1.81+10,058134,047+8%+$18,205-20
DM
2017-04-19
CRSPKulkarni SamarthChief Business OfficerS - Sale+OE$17.73-10,058134,047-7%-$178,376-20
M
2017-04-19
CRSPDylan-Hyde TylerGCS - Sale$17.71-10,177195,027-5%-$180,190-20
D
2016-10-24
CRSPEmster Kurt VonDirC - Converted deriv$0.002,545,8142,601,814-49%$0+9+24+42
D
2016-10-24
CRSPEmster Kurt VonDirP - Purchase$14.00+56,0002,601,814+2%+$784,000+9+24+42
D
2016-10-24
CRSPLundberg Sven AnteChief Scientific OfficerC - Converted deriv$0.0055,2171,010,834-5%$0+2+25+43
D
2016-10-24
CRSPLundberg Sven AnteChief Scientific OfficerP - Purchase$14.00+4001,010,8340%+$5,600+2+25+43
AD
2016-10-24
CRSPVersant Venture Capital Iv, L.P.10%C - Converted deriv$0.006,508,69979,478-99%$0+1-3-10
AD
2016-10-24
CRSPVersant Venture Capital Iv, L.P.10%P - Purchase$14.00+161,00079,478-197%+$2,254,000+1-3-10
D
2016-10-24
CRSPWoiwode ThomasDirC - Converted deriv$0.006,508,699763,492-90%$0+1-3-10
D
2016-10-24
CRSPWoiwode ThomasDirP - Purchase$14.00+161,000763,492+27%+$2,254,000+1-3-10
D
2016-10-24
CRSPBolzon Bradley J PhdDirC - Converted deriv$0.006,508,699763,492-90%$0+1-3-10
D
2016-10-24
CRSPBolzon Bradley J PhdDirP - Purchase$14.00+161,000763,492+27%+$2,254,000+1-3-10
AD
2016-10-24
CRSPCelgene Corp /de/10%C - Converted deriv$0.004,034,8304,834,980-45%$0+6-3+31+8
AD
2016-10-24
CRSPCelgene Corp /de/10%P - Purchase$14.00+800,1504,834,980+20%+$11,202,100+6-3+31+8
2016-10-24
CRSPColes N AnthonyDirA - Grant$14.00+70,000140,000+100%+$980,000+7+22+31+15
2016-10-24
CRSPVersant Venture Capital Iv, L.P.10%A - Grant$14.00+161,000185,987+644%+$2,254,000+7+22+31+15
D
2016-10-24
CRSPGeorge SimeonDirC - Converted deriv$0.003,154,1273,220,627-49%$0+7+22+31+15
D
2016-10-24
CRSPGeorge SimeonDirP - Purchase$14.00+66,5003,220,627+2%+$931,000+7+22+31+15
D
2016-10-24
CRSPGlaxosmithkline Plc10%C - Converted deriv$0.003,154,1273,220,627-49%$0+7+22+31+15
D
2016-10-24
CRSPGlaxosmithkline Plc10%P - Purchase$14.00+66,5003,220,627+2%+$931,000+7+22+31+15
D
2016-10-24
CRSPCelgene Corp /de/10%C - Converted deriv$0.004,034,8304,834,980-45%$0+7+22+31+15
D
2016-10-24
CRSPCelgene Corp /de/10%P - Purchase$14.00+800,1504,834,980+20%+$11,202,100+7+22+31+15
D
2016-10-24
CRSPHadley Harbor Master Investors (Cayman) L.P.10%C - Converted deriv$0.00744,380744,380-50%$0+1+21+51+22

Real-time CSV? Options? Alerts? Contact us!
AAmended filing
DDerivative transaction in filing (usually option exercise)
EError detected in filing
MMultiple transactions in filing; earliest reported transaction date and weighted average transaction price
S - SaleSale of securities on an exchange or to another person
S - Sale+OESale of securities on an exchange or to another person (after option exercise)
F - TaxPayment of exercise price or tax liability using portion of securities received from the company
P - PurchasePurchase of securities on an exchange or from another person
Return to top